IP Library Granted Patent US 8,334,266
Granted Patent B2
US 8,334,266 · App. 13/429,065 · Granted Dec 18, 2012

Process for and intermediates in the preparation of canfosfamide and its salts

Assignee: Telik, Inc.
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,334,266
App. No.
13/429,065
Granted
Dec 18, 2012
Kind
B2
Abstract

A process for and intermediates in the preparation of canfosfamide and its salts. Some of the intermediates have anticancer activity.

Claims (13)

1. A compound of the formula

where R 1 is an amine-protecting group, or its salt.

2. The compound of claim 1 where R 1 is a catalytically removable amine-protecting group.

3. The compound of claim 2 where R 1 is (optionally substituted benzyl)oxycarbonyl or (optionally substituted allyl)oxycarbonyl.

4. The compound of claim 3 where R 1 is benzyloxycarbonyl.

5. A method of preparing canfosfamide or its salt, comprising deprotecting a compound of formula I:

where R 1 is an amine protecting group, or its salt, optionally followed by forming a salt of confosfamide;

wherein the compound of formula I is prepared by a method comprising oxidizing a compound of claim 1 .

6. The method of claim 5 , where the deprotecting comprises catalytic reduction or isomerization.

7. The method of claim 6 , where the deprotecting comprises reaction with hydrogen in the presence of palladium on carbon.

8. The method of claim 5 , where the hydrochloride salt of canfosfamide is formed by the addition of hydrogen chloride gas.

9. The method of claim 5 where R 1 is (optionally substituted benzyl)oxycarbonyl or (optionally substituted allyl)oxycarbonyl.

10. The method of claim 5 where the oxidizing comprises reaction with a persulfate.

Assignments (2)
CHANGE OF NAME Recorded Dec 21, 2016
From: TELIK, INC.
To: MABVAX THERAPEUTICS HOLDINGS, INC.
Reel/Frame 041165/0772 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Nov 6, 2012
From: BOULANGER, WILLIAM A.; COLLIER, STEVEN J.; EASTHAM, STEPHEN A.; EDIE, DENNIS L.; GUEVEL, RONAN Y.; ABAD, PEDRO E. HERNANDEZ; HERR, R. JASON; KJAERSGAARD, HANS J.; MECKLER, HAROLD; POLOMSKI, ROBERT E.; SCHOW, STEVEN R.; ZHICHKIN, PAVEL E.
To: TELIK, INC.
Reel/Frame 029251/0542 →
Continuity (2)
Continuation 11018391 · Dec 21, 2004
Related Publication 20120238772A1 · Sep 20, 2012